David focuses on growth & momentum stocks that are reasonably priced and likely to outperform the market over the long-term. He is a long term investor of quality stocks and uses options for strategy. David told investors to buy in March 2009 at the bottom of the financial crisis. The S&P 500 increased 367% and the Nasdaq increased 685% from 2009 through 2019. He wants to help make people money by investing in high-quality growth stocks.Analyst’s Disclosure: I/we have no stock, option or similar derivative ...

Have you looked into how Perrigo (PRGO) performed internationally during the quarter ending September 2024? Considering the widespread global presence of this drug company, examining the trends in international revenues is essential for assessing its financial resilience and prospects for growth.In the current era of a tightly interconnected global economy, the proficiency of a company to penetrate international markets significantly influences its financial health and trajectory of growth. For investors, t ...

Perrigo Company plc (PRGO) reported adjusted earnings of 81 cents per share in the third quarter of 2024, missing the Zacks Consensus Estimate of 82 cents. The reported figure increased 26.6% year over year, primarily due to improved margins and lower variable expenses.Net sales declined 3.2% year over year to $1.09 billion, missing the Zacks Consensus Estimate of $1.12 billion. The downside was due to lower net sales in the Nutrition category and loss of sales stemming from exited businesses and product li ...

Perrigo Company plc (NYSE:PRGO) Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ET Company Participants Bradley Joseph - Vice President of Global Investor Relations Patrick Lockwood-Taylor - President & Chief Executive Officer Eduardo Bezerra - Chief Financial Officer Conference Call Participants Susan Anderson - Canaccord Keith Devas - Jefferies Korinne Wolfmeyer - Piper Sandler Daniel Biolsi - Hedgeye Operator Good morning, ladies and gentlemen and welcome to the Perrigo Third Quarter 2024 Finan ...

For the quarter ended September 2024, Perrigo (PRGO) reported revenue of $1.09 billion, down 3.2% over the same period last year. EPS came in at $0.81, compared to $0.64 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.11 billion, representing a surprise of -2.43%. The company delivered an EPS surprise of -1.22%, with the consensus EPS estimate being $0.82.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street e ...

Perrigo (PRGO) came out with quarterly earnings of $0.81 per share, missing the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $0.64 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -1.22%. A quarter ago, it was expected that this drug company would post earnings of $0.48 per share when it actually produced earnings of $0.53, delivering a surprise of 10.42%.Over the last four quarters, the company has ...

EXHIBIT 99.1 Perrigo Reports Third Quarter 2024 Financial Results From Continuing Operations Company Delivered Solid Third Quarter Financial Results, Including Meaningful Operating Income Growth and Margin Expansion Infant Formula Business Recovery Making Significant Progress, Including Perrigo Produced and Store Brand Infant Formula Market Share Gains ; Third Quarter 2024 Infant formula Net Sales Growth of +3% Compared to the Prior Year Quarter, +58% Sequentially 1 Reaffirms Fiscal 2024 Adjusted EPS Outloo ...

Company Delivered Solid Third Quarter Financial Results, Including Meaningful Operating Income Growth and Margin ExpansionInfant Formula Business Recovery Making Significant Progress, Including Perrigo Produced and Store Brand Infant Formula Market Share Gains1; Third Quarter 2024 Infant formula Net Sales Growth of +3% Compared to the Prior Year Quarter, +58% SequentiallyReaffirms Fiscal 2024 Adjusted EPS OutlookDUBLIN, Nov. 6, 2024 /PRNewswire/ --Third Quarter 2024 Highlights: Net sales of $1.1 billion dec ...

Perrigo Company plc (PRGO) is scheduled to report third-quarter 2024 earnings on Nov. 6, before the opening bell. In the last reported quarter, the company posted an earnings surprise of 10.42%.The Zacks Consensus Estimate for total revenues is pegged at around $1.12 billion, while that for earnings is pinned at 82 cents per share.Factors Shaping PRGO’s Upcoming ResultsPerrigo reports its results under two segments — Consumer Self Care Americas (CSCA) and Consumer Self Care International (CSCI).We suppose t ...

DUBLIN, Oct. 23, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its third quarter 2024 financial results on Wednesday, November 6, 2024, and host a conference call beginning at 8:30 A.M. (EST). The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 800-836-818 ...